serum prostate-specific antigen ( pa ) , a new tumor marker of prostate cancer , was evaluated with an eznyme immunoassay ( eia ) in various urologic cancer patients and benign prostatic diseases in japanese .
C0376358
of prostate cancer
C0033572
prostatic